🔎 Trials Near Me

Home › Immunoglobulin Light-chain Amyloidosis › Connecticut

Immunoglobulin Light-chain Amyloidosis clinical trials in Connecticut

3 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in Connecticut.

Cities in Connecticut

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis

  • GSK Investigational Site, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07224672

Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis

  • Yale University, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT06569147

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

  • Smilow Cancer Hospital-Derby Care Center, Derby
  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich
  • Smilow Cancer Hospital Care Center - Guilford, Guilford
  • and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06022939

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.